Foresite Capital Management I is an investment fund managing more than $33.9 million ran by James Tananbaum. There is currently 1 company in Mr. Tananbaum’s portfolio. The largest and only investment include 10x Genomics worth $33.9 million.
As of 5th August 2022, Foresite Capital Management I’s top holding is 750,000 shares of 10x Genomics currently worth over $33.9 million and making up 100.0% of the portfolio value.
Relative to the number of outstanding shares of 10x Genomics, Foresite Capital Management I owns more than approximately 0.1% of the company.
Currently, Foresite Capital Management I's portfolio is worth at least $33.9 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Foresite Capital Management I office and employees reside in Larkspur, California. According to the last 13-F report filed with the SEC, James Tananbaum serves as the Managing Member at Foresite Capital Management I.
There are companies that Foresite Capital Management I is getting rid of from its portfolio.
Foresite Capital Management I closed its position in Epizyme Inc on 12th August 2022.
It sold the previously owned 143,759 shares for $165 thousand.
The two most similar investment funds to Foresite Capital Management I are Act Ii Management, L.P. and Lyons Wealth Management,. They manage $33.8 million and $34.1 million respectively.
Foresite Capital Management I’s portfolio is diversified across 1 sector.
Currently, their heaviest sector is Health Care — making up 100.0% of
the total portfolio value.
The fund focuses on investments in the United States as
100.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $5.4 billion.
These positions were updated on August 12th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| 10x Genomics, Inc. |
No change
750,000
|
$33,938,000 | 100.00% |
| Epizyme Inc |
Closed
143,759
|
$165,000 | |
| No transactions found | |||
| Showing first 500 out of 2 holdings | |||